GL Pharm Tech Corp. (KOSDAQ:204840)

GL Pharm Tech Statistics

Total Valuation

GL Pharm Tech has a market cap or net worth of KRW 91.89 billion. The enterprise value is 105.25 billion.

Market Cap	91.89B
Enterprise Value	105.25B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GL Pharm Tech has 77.22 million shares outstanding. The number of shares has increased by 14.76% in one year.

Current Share Class	77.22M
Shares Outstanding	77.22M
Shares Change (YoY)	+14.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	51.53M

Valuation Ratios

The trailing PE ratio is 1,613.02.

PE Ratio	1,613.02
Forward PE	n/a
PS Ratio	3.12
PB Ratio	4.65
P/TBV Ratio	5.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.79, with an EV/FCF ratio of -19.80.

EV / Earnings	1,847.66
EV / Sales	3.57
EV / EBITDA	57.79
EV / EBIT	207.77
EV / FCF	-19.80

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.76.

Current Ratio	1.33
Quick Ratio	0.58
Debt / Equity	0.76
Debt / EBITDA	8.36
Debt / FCF	-2.84
Interest Coverage	0.78

Financial Efficiency

Return on equity (ROE) is 0.29% and return on invested capital (ROIC) is 0.87%.

Return on Equity (ROE)	0.29%
Return on Assets (ROA)	0.70%
Return on Invested Capital (ROIC)	0.87%
Return on Capital Employed (ROCE)	1.67%
Revenue Per Employee	892.27M
Profits Per Employee	1.73M
Employee Count	33
Asset Turnover	0.67
Inventory Turnover	1.89

Taxes

In the past 12 months, GL Pharm Tech has paid 5.43 million in taxes.

Income Tax	5.43M
Effective Tax Rate	8.71%

Stock Price Statistics

The stock price has increased by +10.29% in the last 52 weeks. The beta is 0.92, so GL Pharm Tech's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	+10.29%
50-Day Moving Average	1,155.24
200-Day Moving Average	1,128.93
Relative Strength Index (RSI)	50.83
Average Volume (20 Days)	316,121

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GL Pharm Tech had revenue of KRW 29.44 billion and earned 56.97 million in profits. Earnings per share was 0.74.

Revenue	29.44B
Gross Profit	13.19B
Operating Income	491.11M
Pretax Income	62.40M
Net Income	56.97M
EBITDA	1.81B
EBIT	491.11M
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 1.73 billion in cash and 15.09 billion in debt, giving a net cash position of -13.37 billion or -173.10 per share.

Cash & Cash Equivalents	1.73B
Total Debt	15.09B
Net Cash	-13.37B
Net Cash Per Share	-173.10
Equity (Book Value)	19.76B
Book Value Per Share	256.69
Working Capital	4.70B

Cash Flow

In the last 12 months, operating cash flow was -4.00 billion and capital expenditures -1.31 billion, giving a free cash flow of -5.32 billion.

Operating Cash Flow	-4.00B
Capital Expenditures	-1.31B
Free Cash Flow	-5.32B
FCF Per Share	-68.86

Margins

Gross margin is 44.80%, with operating and profit margins of 1.67% and 0.19%.

Gross Margin	44.80%
Operating Margin	1.67%
Pretax Margin	0.21%
Profit Margin	0.19%
EBITDA Margin	6.13%
EBIT Margin	1.67%
FCF Margin	n/a

Dividends & Yields

GL Pharm Tech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.76%
Shareholder Yield	-14.76%
Earnings Yield	0.06%
FCF Yield	-5.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GL Pharm Tech has an Altman Z-Score of 2.22 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	4